Fady Ibraham Malik - Jun 22, 2023 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
Director
Signature
/s/ Martin Wilson, as attorney-in-fact
Stock symbol
RCKT
Transactions as of
Jun 22, 2023
Transactions value $
$0
Form type
4
Date filed
6/26/2023, 07:47 PM
Previous filing
Jun 8, 2023
Next filing
Jul 13, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RCKT Stock Option (Right to Buy) Award $0 +25.9K $0.00 25.9K Jun 22, 2023 Common Stock 25.9K $21.56 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase a total of 25,850 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 22, 2024.